No Adverse Impact of Obesity in Biologic-Treated IBD - Medscape

People with inflammatory bowel disease and obesity can be safely started on biologic therapies, suggests an analysis of over 3000 patients.

Patients with both inflammatory bowel disease (IBD) and obesity starting on new biologic therapies do not face an increased risk for hospitalization, IBD-related surgery, or serious infection, reveal… [+5685 chars]

full article...